Accuracy of self-reported tobacco use status among hematopoietic SCT patients

Bone Marrow Transplantation

Volumn 49, Issue 7, 2014, Pages 961-965

  Ehlers, S L ^a   Bronars, C A ^a   Patten, C A ^a   Brockman, T ^a   Hughes, C ^a   Decker, P A ^a   Cerhan, J R ^a   Hogan, W ^a   Dispenzieri, A ^a   Ansell, S ^a   Ebbert, J ^a   Gastineau, D ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE;

ADULT; AGE; ARTICLE; BLOOD LEVEL; COTININE BLOOD LEVEL; EDUCATIONAL STATUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; MALE; MARRIAGE; MEASUREMENT ACCURACY; MEDICAL RECORD; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; SELF REPORT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TOBACCO USE; VALIDATION STUDY; BLOOD; EPIDEMIOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES;

COTININE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MINNESOTA; RISK FACTORS; SELF REPORT; TOBACCO USE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 84903881655     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.70     Document Type: Article

References (38)

1. Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 223-229.
2. Miceli MH, Dong L, Grazziutti ML, Fassas A, Thertulien R, Van Rhee F et al. Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients. Bone Marrow Transplant 2006; 37: 857-864.
3. Tran BT, Chien JW. Cigarette Smoking and Allogeneic Hematopoietic Stem Cell Transplant Outcomes. Am J Respir Cirt Care Med 2010; 181: A5434.
4. Bishop MM, Lee SJ, Beaumont JL, Andrykowski MA, Rizzo JD, Sobocinski KA et al. The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. Biol Blood Marrow Transplant 2010; 16: 207-214.
5. Armenian SH, Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ et al. Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor Study. Bone Marrow Transplant 2012; 47: 283-290.
6. Chang G, Orav EJ, McNamara T, Tong MY, Antin JH. Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome. Cancer 2004; 101: 782-789.
7. Savani BN, Montero A, Wu C, Nlonda N, Read E, Dunbar C et al. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 223-230.
8. Tran BT, Halperin A, Chien JW. Cigarette smoking and outcomes after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 1004-1011.
9. Ehlers SL, Gastineau DA, Patten CA, Decker PA, Rausch SM, Cerhan JR et al. The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia. Bone Marrow Transplant 2011; 46: 285-290.
10. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther 2012; 5: 1-30.
11. Wagenknecht LE, Burke GL, Perkins LL, Haley NJ, Friedman GD. Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. Am J Public Health 1992; 82: 33-36.
12. Vartiainen E, Seppala T, Lillsunde P, Puska P. Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health 2002; 56: 167-170.
13. West R, Zatonski W, Przewozniak K, Jarvis MJ. Can we trust national smoking prevalence figures? Discrepancies between biochemically assessed and selfreported smoking rates in three countries. Cancer Epidemiol Biomarkers Prev 2007; 16: 820-822.
14. Connor Gorber S, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res 2009; 11: 12-24.
15. Javors MA, Hatch JP, Lamb RJ. Sequential combination of self-report, breath carbon monoxide, and saliva cotinine to assess smoking status. Drug Alcohol Depend 2011; 113: 242-244.
16. Fisher MA, Taylor GW, Shelton BJ, Debanne SM. Sociodemographic characteristics and diabetes predict invalid self-reported non-smoking in a population-based study of U.S. adults. BMC Public Health 2007; 7: 33.
17. Murray RP, Connett JE, Lauger GG, Voelker HT. Error in smoking measures: effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. The Lung Health Study Research Group. Am J Public Health 1993; 83: 1251-1257.
18. Hsieh SJ, Ware LB, Eisner MD, Yu L, Jacob P 3rd, Havel C et al. Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients. Crit Care Med 2011; 39: 40-45.
19. Waggoner SE, Darcy KM, Fuhrman B, Parham G, Lucci J 3rd, Monk BJ et al. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a gynecologic oncology group study. Gynecol Oncol 2006; 103: 853-858.
20. Gritz ER, Carr CR, Rapkin D, Abemayor E, Chang LJ, Wong WK et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993; 2: 261-270
21. Mehra MR, Uber PA, Prasad A, Scott RL, Park MH. Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with atherothrombosis risk markers. Am J Transplant 2005; 5: 1137-1140.
22. Bright RP, Civalier KM, Krahn L. Reliability of self-reported nicotine use as determined by serum cotinine levels in patients referred for liver transplantation. Psychosomatics 2010; 51: 395-400.
23. Studts JL, Ghate SR, Gill JL, Studts CR, Barnes CN, LaJoie AS et al. Validity of selfreported smoking status among participants in a lung cancer screening trial. Cancer Epidemiol Biomarkers Prev 2006; 15: 1825-1828.
24. Stuber J, Galea S. Who conceals their smoking status from their health care provider? Nicotine Tob Res 2009; 11: 303-307.
25. Ehlers S, Bronars C. Effect of smoking on the outcomes of cancer patients after hematopoietic stem cell transplantation. In: Hayat MA (ed.). Stem Cells and Cancer Stem Cells, vol. 8. Springer: Dordrecht, The Netherlands, 2012.
26. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4: 149-159.
27. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003; 5: 13-25.
28. Wilson JS, Elborn JS, Fitzsimons D, McCrum-Gardner E. Do smokers with chronic obstructive pulmonary disease report their smoking status reliably? A comparison of self-report and bio-chemical validation. Int J Nurs Stud 2011; 48: 856-862.
29. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 2009; 169: 236-248.
30. Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR et al. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin Chem 2002; 48: 1460-1471.
31. Fiore, MC Jaén, CR Baker, TB, The Clincial Practice Guideline Panel. Treating tobacco use and dependence: 2008 update. In: Quick Reference Guide for Clinicians. Department of Health and Human Services, Public Health Service: Rockville, MD, USA, 2009.
32. Gritz ER, Schacherer C, Koehly L, Nielsen IR, Abemayor E. Smoking withdrawal and relapse in head and neck cancer patients. Head Neck 1999; 21: 420-427.
33. Cooley ME, Sarna L, Kotlerman J, Lukanich JM, Jaklitsch M, Green SB et al. Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer 2009; 66: 218-225.
34. Walker MS, Vidrine DJ, Gritz ER, Larsen RJ, Yan Y, Govindan R et al. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2370-2377.
35. Evangelista L, Ter-Galstanyan A, Moser DK, Dracup K. Smoking among women following heart transplantation: should we be concerned? Prog Cardiovasc Nurs 2009; 24: 119-123.
36. Lewis SJ, Cherry NM, McL Niven R, Barber PV, Wilde K, Povey AC. Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinic. Biomarkers 2003; 8: 218-228.
37. Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005; 23: 5814-5830.
38. Ehlers SL. Ethical analysis and consideration of health behaviors in organ allocation: focus on tobacco use. Transplant Rev (Orlando) 2008; 22: 171-177.